3D InSight™ NAFLD (MASLD) Model for Screening and Discovery

Understand the biology of fatty liver disease and screen for small molecules and biologicals - all in the same in vitro platform.

Leveraging InSphero's market-leading 3D InSight™ NASH (MASH) model, our NAFLD (recently renamed to MASLD - Metabolic Dysfunction-associated Steatotic Liver Disease) platform offers equivalent advantages for fatty liver disease research. Experience a high-quality, scalable, and human-relevant 3D in vitro disease model that generates precise insights and facilitates efficient research throughput. Rely on our expertise in creating primary-cell spheroid models and inducing specific disease phenotypes, enabling us to tailor solutions to your needs - faster and more efficiently than anyone else.

Why NAFLD Screening with InSphero?

We inspire researchers, worldwide, to reach their full potential so that life changing therapies can ultimately make it into the hands of patients.

Predictive and robust human liver biology you can trust

As complex as necessary and as simple as possible. Our research credo at work. Based on co-culturing disease relevant primary cells, our model mimics NAFLD accurately

Continuity from screening to mechanistic research

Our NAFLD model is not only great for mechanistic research, it is also perfect for automated screening on all automation platforms

Understand the impact of genetic variants (SNPs)

3D InSight™ NAFLD models are available in multi-donor form or based on single donors including metabolically relevant SNPs (e.g., PNPLA3, HSD17B13)

10x faster results get you closer to the cure

10x faster, that is the time you save going in vitro instead of animal models. Faster data, more insights, quicker iterations to find and assess your compound

Your Success is Our Mission

Schedule a consultation with our experts

Our Process

3D InSight™ Liver Microtissue formation

Primary human hepatocytes (PHHs), Kupffer cells, and liver endothelial cells (LECs)

Lipid loading

Using an optimized treatment with free fatty acids and elevated sugar concentration

Compound dosing

Multiple compound addition steps to mimic regular intake

Multiparametric readouts

Quantification of lipid content using biochemical or advanced imaging assays

3D InSight™ Human Liver Microtissue
Lorem ipsum dolor sit amet consectetur adipiscing elit dolor
Click Here
Slide 1 Heading
Lorem ipsum dolor sit amet consectetur adipiscing elit dolor
Click Here
Previous slide
Next slide

Featured resources

Modeling NAFLD: From Steatosis to NASH and Fibrosis
3D InSight™ Liver Platform for Liver Disease Research

Related products

3D InSight™ Human Liver Microtissues
Scroll to Top

Your Success is Our Mission - Get in Touch

Fill in form below to contact our 3D in vitro experts

Sign up for our Newsletter - Get the latest news on 3D in vitro research

View resource

Fill in the form below to view this resource